TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.3, pp.220-227, 2019 (SCI-Expanded)
Background/Aims: This study aimed to determine a predictive bioindicator that would detect the treatment response of patients diagnosed with rectal cancer and treated with neoadjuvant chemoradiotherapy (nCRT).